Average Co-Inventor Count = 5.02
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (14 from 2,405 patents)
2. Idenix Pharmaceuticals, Inc. (3 from 100 patents)
14 patents:
1. 11958864 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
2. 11413292 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
3. 11123355 - Antiviral benzyl-amine phosphodiamide compounds
4. 10745428 - Antiviral phosphodiamide prodrugs of tenofovir
5. 10736908 - Antiviral aryl-amide phosphodiamide compounds
6. 9822138 - Antiviral beta-amino acid ester phosphodiamide compounds
7. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
8. 9643982 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
9. 9636337 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
10. 9278960 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
11. 9108937 - Positive allosteric modulators of mGluR2
12. 8975261 - Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors
13. 8629275 - AHCY hydrolase inhibitors for treatment of hyper homocysteinemia
14. 8329697 - Imidizo[1,2-A]pyrazines useful as AHCY hydrolase inhibitors